Evidence map›Paper›PMID 30269272›Full record

ArticleDigestive diseases and sciences2019

Homoectoine Protects Against Colitis by Preventing a Claudin Switch in Epithelial Tight Junctions.

Karla F Castro-Ochoa, Hilda Vargas-Robles, Sandra Chánez-Paredes, Alfonso Felipe-López, Rodolfo I Cabrera-Silva, Mineko Shibayama, Abigail Betanzos, Porfirio Nava, Erwin A Galinski, Michael Schnoor

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Ectoine attenuates HFrontiers in aging · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fullerenol CInternational journal of nanomedicine · 2024
    Article
  10. Review
  11. Article
  12. Administration ofBioscience of microbiota, food and health · 2023
    Article
  13. Review
  14. Article
  15. Journal of Zhejiang University. Science. B · 2022
    Article
  16. Article
  17. Regulatory Effect ofFoods (Basel, Switzerland) · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Karla F Castro-OchoaDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Hilda Vargas-RoblesDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Sandra Chánez-ParedesDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Alfonso Felipe-LópezDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Rodolfo I Cabrera-SilvaDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Mineko ShibayamaDepartment of Infectomics and Molecular Pathogenesis, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Abigail BetanzosDepartment of Infectomics and Molecular Pathogenesis, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Porfirio NavaDepartment of Physiology, Biophysics and Neurosciences, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico.
Erwin A GalinskiInstitute of Microbiology and Biotechnology, University of Bonn, 53115, Bonn, Germany.
Michael SchnoorDepartment of Molecular Biomedicine, CINVESTAV, Avenida IPN 2508, San Pedro Zacatenco, 07360, Mexico-City, Mexico. mschnoor@cinvestav.mx.ORCID 0000-0002-0269-5884
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXUniversidad Insurgentes · MXUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammatory bowel diseases (IBD) are multifactorial disorders affecting millions of people worldwide with alarmingly increasing incidences every year. Dysfunction of the intestinal epithelial barrier is associated with IBD pathogenesis, and therapies include anti-inflammatory drugs that enhance intestinal barrier function. However, these drugs often have adverse side effects thus warranting the search for alternatives. Compatible solutes such as bacterial ectoines stabilize cell membranes and proteins.

aimTo unravel whether ectoine (1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid) and homoectoine (4,5,6,7-tetrahydro-2-methyl-1H-(1,3)-diazepine-4-carboxylic acid), a synthetic derivative of ectoine, have beneficial effects during dextran sulfate sodium (DSS)-induced colitis in mice. METHODS/

resultsWe found that the disease activity index was significantly reduced by both ectoines. DSS-induced edema formation, epithelial permeability, leukocyte recruitment and tissue damage were reduced by ectoine and homoectoine, with the latter having stronger effects. Interestingly, the claudin switch usually observed during colitis (decreased expression of claudin-1 and increased expression of the leaky claudin-2) was completely prevented by homoectoine, whereas ectoine only reduced claudin-2 expression. Concomitantly, only homoectoine ameliorated the drop in transepithelial electrical resistance induced by IFN-γ and TNF-α in Caco-2 cells. Both ectoines inhibited loss of ZO-1 and occludin and prevented IFN-γ/TNF-α-induced increased paracellular flux of 4 kDa FITC-dextran in vitro. Moreover, both ectoines reduced expression of pro-inflammatory cytokines and oxidative stress during colitis.

conclusionWhile both ectoine and homoectoine have protective effects on the epithelial barrier during inflammation, only homoectoine completely prevented the inflammatory claudin switch in tight junctions. Thus, homoectoine may serve as diet supplement in IBD patients to reach or extend remission.

Indexed as

Amino Acids, DiaminoAnimalsCaco-2 CellsClaudin-1Claudin-2ColitisDextran SulfateDisease Models, AnimalEdemaElectric ImpedanceEpitheliumHumansInterferon-gammaIn Vitro TechniquesMaleMiceAmino Acids, DiaminoClaudin-1Claudin-2Dextran SulfateectoinehomoectoineInterferon-gammaTumor Necrosis Factor-alphaDextran sulfate sodiumEctoineIntestinal permeabilityPro-inflammatory cytokinesTight junction

Identifiers

PMID30269272
OpenAlexW2892511007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.